InvestorsHub Logo
Followers 297
Posts 19980
Boards Moderated 1
Alias Born 05/05/2014

Re: None

Tuesday, 04/13/2021 1:43:13 PM

Tuesday, April 13, 2021 1:43:13 PM

Post# of 127
Just like today's mega announcement by FUAPF about them Closing Largest Revenue Deal for its Efixii ‘Seed to Seed’ Platform with Malta Based Medical Cannabis Cultivator, ... so APHA is Why this cannabis giant is betting on Europe to build a war chest ahead of the U.S. legalization bonanza ... High-margin medical pot businesses in Europe are a major boost. TLRY has also expanded into Europe with its medical cannabis applications/solutions.

https://www.marketwatch.com/story/why-this-cannabis-giant-is-betting-on-europe-to-build-a-war-chest-ahead-of-the-u-s-legalization-bonanza-11617990136?fbclid=IwAR3zbzYvLKfSX5RSFsA5wuigcbZy0onLvwNb6KdstuNCEa-J2jpiKvcRY7o

Bottom line:

We think FUAPF has the largest growth potential in generating high-margin revenue with low overhead and its unique approach as well as regarding the stock price advances due its still low valuation. Overall its definitely the right direction for FUAPF, APHA, TLRY etc. to focus on the European medical cannabis market with the currently highest growth and potential to finally expand globally. Put FUAPF on your watchlist as well as a comparison APHA and TLRY (merger coming soon).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APP News